Treating nondementia illnesses in patients with dementia

JAMA

Volumn 283, Issue 24, 2000, Pages 3230-3235

  Brauner, Daniel J ^a,c   Muir, J Cameron ^b   Sachs, Greg A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE REPORT; COGNITION; COMORBIDITY; DEMENTIA; FEMALE; HEALTH CARE QUALITY; HUMAN; MEDICAL DECISION MAKING; PATIENT CARE; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0034725349     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.24.3230     Document Type: Article

References (42)

1. Larson EB. Management of Alzheimer's disease in a primary care setting. Am J Geriatr Psychiatry. 1998; 6:S34-540.
2. Gambert SR. Alzheimer's disease for the primary care physician. Compr Ther. 1997;23:174-178.
3. Barrett JJ, Haley WE, Powers RE. Alzheimer's disease patients and their caregivers: medical care issues for the primary care physician. South Med J. 1996; 89:1-9.
4. Eccles M, Clarke J, Livingstone M, Freemantle N, Mason J. North of England evidence based guidelines development project: guideline for the primary care management of dementia. BMJ. 1998;317:802-808.
5. Guttman R, Seleski M, eds. Diagnosis, Management and Treatment of Dementia: A Practical Guide for Primary Care Physicians. Chicago, Ill: American Medical Association; 1999.
6. Rhymes JA, McCullough LB, Luchi RJ, Teasdale TA, Wilson N. Withdrawing very low-burden interventions in chronically ill patients. JAMA. 2000;283:1061-1063.
7. Thorpe J, Widman LP, Walin A, Beiswanger J, Blumenthal HT. Comorbidity of other chronic age-dependent diseases in dementia. Aging Clin Exp Res. 1994;6:159-166.
8. Larson EB, Reifler BV, Sumi SM, Canfield CG, Chinn NM. Features of potentially reversible dementia in elderly outpatients. West J Med. 1986;145: 488-492.
9. Irvine P. An approach to the management of medical problems in demented patients. Clin Geriatr Med. 1988;4:703-717.
10. Small GW, Rabins RV, Barry PP, et al. Diagnosis and treatment of Alzheimer disease and related disorders: Consensus Statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA. 1997;278:1363-1371.
11. Rango J. The nursing home resident with dementia: clinical care, ethics, and policy implications. Ann Intern Med. 1985;102:835-841.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
13. Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med. 1995;333:1437-1443.
14. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate of risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1535-1541.
15. de Groen PC, Dieter FL, Hirsch LJ, et al. Esophagitis associated with the use of alendronate. N Engl J Med. 1996;335:1016-1021.
16. Grisso T, Appelbaum PS. Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals. New York, NY: Oxford Press; 1998.
17. Etchells E, Darzins P, Silberfeld M, et al. Assessment of patient capacity to consent to treatment. J Gen Intern Med. 1999;14:27-34.
18. Marson DC, Cody HA, Ingram KK, Harell LE. Neuropsychologic predictors of competency in Alzheimer's disease using a rational reasons legal standard. Arch Neurol. 1995;52:955-959.
19. Drane JF. Competency to give an informed consent: a model for making clinical assessments. JAMA. 1984;252:925-927.
20. Appelbaum PS, Grisso T. Assessing patients' capacities to consent to treatment. N Engl J Med. 1988; 319:1635-1638.
21. Sachs GA, Stocking CB, Stern R, Cox DM, Hougham C, Sachs RS. Ethical aspects of dementia research: informed consent and proxy consent. Clin Res. 1994;42:403-412.
22. Karlawish JH, Quill T, Meier DE. A consensus-based approach to providing palliative care to patients who lack decision-making capacity. Ann Intern Med. 1999;130:835-840
23. Issac LM, Tamblyn RM. Compliance and cognitive function: a methodological approach to measuring unintentional errors in medication compliance in the elderly. Gerontologist. 1993;33:772-781.
24. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991;114:956-966.
25. Murdoch BE, Chenery HJ, Wilks V, Boyle RS. Language disorders in dementia of the Alzheimer type. Brain Lang. 1987;31:122-137.
26. Ripich DN, Wykle M, Niles S. Alzheimer's disease caregivers: the focused program. Geriatr Nursing. 1995;16:15-19.
27. Hamilton HE. Conversations With an Alzheimer's Patient. Cambridge, England: Cambridge University Press; 1994.
28. Clark HH, Schaefer EF. Contributing to discourse. Cognit Sci. 1989;13:259-294.
29. Lee VK. Language changes and Alzheimer's disease: a literature review. J Gerontol Nurs. 1991;17: 16-20.
30. Walsh JS, Welch GH, Larson EB. Survival of out-patients with Alzheimer-type dementia. Ann Intern Med 1990;113:429-434.
31. Black DM, Cummings SR, Karpf DB, et al. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1535-1541.
32. Gorelick PB, Sacco RL, Smith DB, et al. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA. 1999;281:1112-1120.
33. Morris JC, Rubin EH, Morris EJ, Mandel SA. Senile dementia of the Alzheimer's type: an important risk factor for serious falls. J Gerontol. 1987;42:412-417.
34. Matchar DB, McCrory DC, Barnett HJM, Feussner JR. Medical treatment for stroke prevention. Ann Intern Med. 1994;121:41-53.
35. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Alexandria, Va: International Medical Publishing; 1996.
36. Wolf-Klein GP, Silverstone FA. Weight loss in Alzheimer's disease: an international review of the literature, Int Psychogeriatr. 1994;6:135-142.
37. Garber AM, Browner WS, Hulley SB. Clinical guideline, part 2: cholesterol screening in asymptomatic adults, revisited. Ann Intern Med. 1996;124:518-531.
38. Luchins DJ, Hanrahan P, Murphy K, Criteria for enrolling dementia patients in hospice. J Am Geriatr Soc. 1997;45:1054-1059.
39. Sachs GA. Dementia and the goals of care. J Am Geriatr Soc. 1998;46:782-783.
40. Post SG, Whitehouse PJ. Emerging antidementia drugs: a preliminary ethical view. J Am Geriatr Soc. 1998;46:784-787.
41. National Institutes of Health. NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Available at: http://grants.nih.gov /grants/oprr/humansubjects/guidance/59fr14508 .htm. Accessed May 5, 2000.
42. National Institutes of Health. Policy and guidelines on the inclusion of children as participants in research involving human subjects. Available at: http:// grants.nih.gov/grants/guide/notice-files/not98-024.html. Accessed May 5, 2000.